Encompass Health reports Q4 and FY 2023 results; no specific figures in filing text

Encompass Health Corp

2023-FY EPS reported $3.47 revenue$4,801,200,000

Q4 and full-year 2023 financial results announced on Feb 7, 2024.
Press release includes non-GAAP measures: adjusted EPS, Adjusted EBITDA, adjusted free cash flow.
Supplemental slides provided for Feb 8 earnings call; specific revenue and EPS not extractable from this filing.
Company uses same-store comparisons for performance metrics.
Forward-looking statements and reconciliation of non-GAAP measures are included.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Encompass Health Corp reported financial results for the three months and year ended December 31, 2023.

Period: the three months and year ended December 31, 2023
Result: reported results

Exact text from the filing

On February 7, 2024, Encompass Health Corporation (“Encompass Health” or the “Company”) issued a press release reporting the financial results of the Company for the three months and year ended December 31, 2023.

View on SEC.gov

20 earnings releases filed in the last 30 days. Browse all earnings releases →

Encompass Health Corp filing history →

Source: SEC EDGAR

accession 0000785161-24-000003

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.